These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36743806)

  • 41. Memantine enhances recovery from stroke.
    López-Valdés HE; Clarkson AN; Ao Y; Charles AC; Carmichael ST; Sofroniew MV; Brennan KC
    Stroke; 2014 Jul; 45(7):2093-2100. PubMed ID: 24938836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.
    Wahlgren NG; Ahmed N
    Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition.
    Jung KH; Chu K; Lee ST; Park HK; Kim JH; Kang KM; Kim M; Lee SK; Roh JK
    Biochem Biophys Res Commun; 2009 Jan; 378(3):507-12. PubMed ID: 19056343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.
    Chen HS; Wang YF; Rayudu PV; Edgecomb P; Neill JC; Segal MM; Lipton SA; Jensen FE
    Neuroscience; 1998 Oct; 86(4):1121-32. PubMed ID: 9697119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence.
    Danysz W; Parsons CG
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-methyl-D-aspartate antagonists for stroke and head trauma.
    Wood PL; Hawkinson JE
    Expert Opin Investig Drugs; 1997 Apr; 6(4):389-97. PubMed ID: 15989606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
    Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
    Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
    Pringle AK; Self J; Eshak M; Iannotti F
    Eur J Neurosci; 2000 Nov; 12(11):3833-42. PubMed ID: 11069578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies.
    Hoque A; Hossain MI; Ameen SS; Ang CS; Williamson N; Ng DC; Chueh AC; Roulston C; Cheng HC
    Pharmacol Ther; 2016 Apr; 160():159-79. PubMed ID: 26899498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure to improve the effect of thrombolysis by memantine in a rat embolic stroke model.
    Back T; Otto D; Kittner D; Schüler OG; Hennerici MG; Mennel HD
    Neurol Res; 2007 Apr; 29(3):264-9. PubMed ID: 17509225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury.
    Liu C; Lin N; Wu B; Qiu Y
    Brain Res; 2009 Jul; 1282():173-82. PubMed ID: 19501064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death.
    Marutani E; Kosugi S; Tokuda K; Khatri A; Nguyen R; Atochin DN; Kida K; Van Leyen K; Arai K; Ichinose F
    J Biol Chem; 2012 Sep; 287(38):32124-35. PubMed ID: 22815476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Memantine inhibits [3H]MK-801 binding to human hippocampal NMDA receptors.
    Berger W; Deckert J; Hartmann J; Krotzer C; Kornhuber J; Ransmayr G; Heinsen H; Beckmann H; Riederer P
    Neuroreport; 1994 Jun; 5(10):1237-40. PubMed ID: 7919173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke.
    Yeh CY; Bulas AM; Moutal A; Saloman JL; Hartnett KA; Anderson CT; Tzounopoulos T; Sun D; Khanna R; Aizenman E
    J Neurosci; 2017 Jun; 37(23):5648-5658. PubMed ID: 28483976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.
    Glasgow NG; Povysheva NV; Azofeifa AM; Johnson JW
    J Neurosci; 2017 Oct; 37(40):9686-9704. PubMed ID: 28877967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats.
    Rao VL; Dogan A; Todd KG; Bowen KK; Dempsey RJ
    Brain Res; 2001 Aug; 911(1):96-100. PubMed ID: 11489449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Efficacy and Safety of Pharmacological Treatments for Post-stroke Aphasia.
    Zhang X; Shu B; Zhang D; Huang L; Fu Q; Du G
    CNS Neurol Disord Drug Targets; 2018; 17(7):509-521. PubMed ID: 29984673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.